citrulline and Hyperlipoproteinemia Type II

citrulline has been researched along with Hyperlipoproteinemia Type II in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beyer-Westendorf, J; Bornstein, SR; Bramlage, P; Jabs, N; Julius, U; Kuhlisch, E; Schellong, SM; Seitz, W1
Boer, P; Hijmering, M; Kastelein, J; Koomans, H; Lagerwerf, F; Rabelink, T; Stroes, E; van Rijn, H; Verhaar, M; Versluis, K; Wever, R1

Other Studies

2 other study(ies) available for citrulline and Hyperlipoproteinemia Type II

ArticleYear
Nitric oxide and endothelin after lipid apheresis - a pilot study.
    Atherosclerosis. Supplements, 2009, Dec-29, Volume: 10, Issue:5

    Topics: Adult; Aged; Analysis of Variance; Arginine; Atherosclerosis; Biomarkers; Blood Component Removal; Case-Control Studies; Citrulline; Endothelin-1; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Nitric Oxide; Pilot Projects; Treatment Outcome

2009
Nitric oxide production is reduced in patients with chronic renal failure.
    Arteriosclerosis, thrombosis, and vascular biology, 1999, Volume: 19, Issue:5

    Topics: Arginine; Arteriosclerosis; Blood Pressure; Cholesterol; Citrulline; Creatinine; Female; Humans; Hyperlipoproteinemia Type II; Kidney Failure, Chronic; Male; Nitric Oxide; Risk Factors; Smoking; Triglycerides

1999